focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

24 Dec 2018 11:05

RNS Number : 4426L
GoldmanSachs International
24 December 2018
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

SHIRE PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

SHIRE PLC

(d) Date dealing undertaken:

21 December 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES - disclosed previously for TAKEDA PHARMACEUTICAL COMPANY LIMITED

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary

Purchases

41,907,116989,560

45.9643 GBP57.4691 USD

44.5220 GBP56.4975 USD

Ordinary

Sales

30,064,3363,330

45.8600 GBP56.3746 USD

44.6100 GBP56.3746 USD

ADR / (1.00 : 3.00)

Purchases

18,855 (56,565)

171.4280 USD

169.6040 USD

ADR / (1.00 : 3.00)

Sales

18,855 (56,565)

171.1783 USD

169.5923 USD

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Ordinary

CFD

Opening a short position

18,982

44.7659 GBP

Ordinary

CFD

Opening a short position

47

44.8950 GBP

Ordinary

CFD

Reducing a short position

162

44.8950 GBP

Ordinary

CFD

Reducing a short position

195

44.8950 GBP

Ordinary

CFD

Reducing a short position

85

44.8950 GBP

Ordinary

CFD

Reducing a short position

30

44.8950 GBP

Ordinary

CFD

Reducing a long position

4,616

44.8950 GBP

Ordinary

CFD

Opening a short position

30,555

44.9040 GBP

Ordinary

CFD

Opening a long position

5,000

44.9050 GBP

Ordinary

CFD

Reducing a long position

5,000

44.9050 GBP

Ordinary

CFD

Opening a short position

150,000

44.9174 GBP

Ordinary

CFD

Reducing a long position

36,000

44.9309 GBP

Ordinary

CFD

Reducing a long position

42,755

44.9450 GBP

Ordinary

CFD

Opening a short position

223,457

44.9450 GBP

Ordinary

CFD

Opening a long position

40,000

44.9875 GBP

Ordinary

CFD

Opening a short position

450,000

45.0035 GBP

Ordinary

CFD

Opening a short position

5,685

45.0065 GBP

Ordinary

CFD

Opening a short position

314,000

45.0112 GBP

Ordinary

CFD

Opening a short position

87,803

45.0148 GBP

Ordinary

CFD

Reducing a short position

33,670

45.0201 GBP

Ordinary

CFD

Reducing a long position

50,000

45.0680 GBP

Ordinary

CFD

Reducing a short position

47

45.0850 GBP

Ordinary

CFD

Opening a long position

13,327

45.0850 GBP

Ordinary

CFD

Reducing a short position

150,000

45.1200 GBP

Ordinary

CFD

Opening a long position

30,555

45.1329 GBP

Ordinary

CFD

Opening a long position

87,803

45.1566 GBP

Ordinary

CFD

Increasing a long position

6,703

45.2500 GBP

Ordinary

CFD

Reducing a short position

3,330

56.3746 USD

Ordinary

CFD

Increasing a short position

2,622

56.4857 USD

Ordinary

CFD

Increasing a short position

10,000

56.4975 USD

Ordinary

CFD

Increasing a short position

20,000

56.8899 USD

Ordinary

CFD

Opening a short position

112,722

56.9266 USD

Ordinary

CFD

Increasing a short position

329,000

56.9544 USD

Ordinary

CFD

Increasing a short position

500

57.1908 USD

Ordinary

CFD

Increasing a short position

6,000

57.2482 USD

Ordinary

CFD

Increasing a short position

500

57.3125 USD

Ordinary

CFD

Increasing a short position

500

57.3517 USD

Ordinary

CFD

Increasing a short position

500

57.3591 USD

Ordinary

CFD

Increasing a short position

622

57.3756 USD

Ordinary

CFD

Increasing a short position

2,394

57.4690 USD

Ordinary

CFD

Increasing a short position

38,934

57.4690 USD

Ordinary

CFD

Increasing a short position

21,672

57.4690 USD

Ordinary

CFD

Opening a short position

350,000

57.4691 USD

Ordinary

CFD

Increasing a short position

23,838

57.4691 USD

Ordinary

SWAP

Reducing a long position

50,000

44.9040 GBP

Ordinary

SWAP

Reducing a long position

40,000

44.9040 GBP

Ordinary

SWAP

Reducing a long position

25,000

44.9040 GBP

Ordinary

SWAP

Reducing a long position

25,000

44.9040 GBP

Ordinary

SWAP

Opening a long position

40,000

44.9235 GBP

Ordinary

SWAP

Opening a long position

25,000

45.1684 GBP

Ordinary

SWAP

Opening a short position

8,277

56.8532 USD

Ordinary

SWAP

Opening a short position

51,723

56.8532 USD

Ordinary

SWAP

Opening a short position

2,069

56.8532 USD

Ordinary

SWAP

Opening a short position

12,931

56.8532 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

3 (900)

177.5000 USD

AMERICAN

28/12/2018

0.6500 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

3 (900)

177.5000 USD

AMERICAN

28/12/2018

0.4567 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

2 (600)

180.0000 USD

AMERICAN

11/01/2019

1.2200 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

2 (600)

180.0000 USD

AMERICAN

11/01/2019

1.3400 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

2 (600)

195.0000 USD

AMERICAN

18/01/2019

0.3950 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

195.0000 USD

AMERICAN

18/01/2019

0.3500 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Purchasing

5 (1,500)

195.0000 USD

AMERICAN

18/01/2019

0.3880 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

162.5000 USD

AMERICAN

11/01/2019

11.2000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

162.5000 USD

AMERICAN

11/01/2019

10.8000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

162.5000 USD

AMERICAN

11/01/2019

10.7000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

2 (600)

162.5000 USD

AMERICAN

11/01/2019

10.7000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

4 (1,200)

162.5000 USD

AMERICAN

11/01/2019

11.1000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

165.0000 USD

AMERICAN

28/12/2018

7.0067 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

2 (600)

165.0000 USD

AMERICAN

11/01/2019

8.6400 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

165.0000 USD

AMERICAN

11/01/2019

8.3000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

2 (600)

167.5000 USD

AMERICAN

11/01/2019

6.3200 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

177.5000 USD

AMERICAN

28/12/2018

0.6500 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

5 (1,500)

180.0000 USD

AMERICAN

18/01/2019

1.8880 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

5 (1,500)

180.0000 USD

AMERICAN

18/01/2019

1.9500 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

3 (900)

180.0000 USD

AMERICAN

18/01/2019

2.0000 USD

ADR / (1.00 : 3.00)

Call Option / (1.00 : 300.00)

Selling

2 (600)

185.0000 USD

AMERICAN

18/01/2019

0.9950 USD

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

24 December 2018

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBBBDDXGDBGIS
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.